Study of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:May 10, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumorLast Updated:May 10, 2023Recruiting
Condition(s):Neoplasms, PancreaticLast Updated:July 31, 2020Terminated
Condition(s):Gastric AdenocarcinomaLast Updated:December 24, 2020Terminated
Condition(s):Lymphoma; Non-Hodgkin; Hodgkin LymphomaLast Updated:March 26, 2024Recruiting
Condition(s):Solid TumorLast Updated:October 28, 2020Unknown status
Condition(s):Cancer; Solid TumorsLast Updated:May 6, 2023Terminated
Condition(s):Ovarian Cancer; OrganoidLast Updated:January 3, 2022Unknown status
Condition(s):Quality of Life; Oral Mucositis; Dental Plaque; Periodontal Diseases; Xerostomia; DysbiosisLast Updated:November 13, 2023Enrolling by invitation
Condition(s):Advanced Rare Malignant Solid Neoplasm; Rare Malignant Solid Neoplasm; Refractory Rare Malignant Solid NeoplasmLast Updated:March 6, 2024Recruiting
Condition(s):Ovarian Cancer; Lung AdenocarcinomaLast Updated:March 4, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.